1304317003: Product containing precisely bictegravir (as bictegravir sodium) 50 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 milligram/1 each conventional release oral tablet (clinical drug)

• SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...
• \Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing transferase inhibitor (product)\...
• \Product containing nucleotidyltransferase inhibitor (product)\Product containing integrase strand transfer inhibitor (product)\Bictegravir-containing product\Product containing bictegravir and emtricitabine and tenofovir (medicinal product)\...
• \Product containing only bictegravir and emtricitabine and tenofovir (medicinal product)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
• \Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
• \Product containing reverse transcriptase inhibitor (product)\Product containing emtricitabine (medicinal product)\Emtricitabine-containing product in oral dose form\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
• \Product containing reverse transcriptase inhibitor (product)\Product containing emtricitabine (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing bictegravir and emtricitabine and tenofovir (medicinal product)\Product containing only bictegravir and emtricitabine and tenofovir (medicinal product)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
• \Product containing reverse transcriptase inhibitor (product)\Product containing emtricitabine (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing bictegravir and emtricitabine and tenofovir (medicinal product)\Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
• \Product containing reverse transcriptase inhibitor (product)\Product containing emtricitabine (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
• \Product containing reverse transcriptase inhibitor (product)\Product containing tenofovir (medicinal product)\Product containing tenofovir in oral dose form (medicinal product form)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
• \Product containing reverse transcriptase inhibitor (product)\Product containing tenofovir (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing bictegravir and emtricitabine and tenofovir (medicinal product)\Product containing only bictegravir and emtricitabine and tenofovir (medicinal product)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
• \Product containing reverse transcriptase inhibitor (product)\Product containing tenofovir (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing bictegravir and emtricitabine and tenofovir (medicinal product)\Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
• \Product containing reverse transcriptase inhibitor (product)\Product containing tenofovir (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
• \Medicinal product categorized by structure\Bictegravir-containing product\Product containing bictegravir and emtricitabine and tenofovir (medicinal product)\Product containing only bictegravir and emtricitabine and tenofovir (medicinal product)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
• \Medicinal product categorized by structure\Bictegravir-containing product\Product containing bictegravir and emtricitabine and tenofovir (medicinal product)\Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
• \Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing tenofovir (medicinal product)\Product containing tenofovir in oral dose form (medicinal product form)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
• \Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing tenofovir (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing bictegravir and emtricitabine and tenofovir (medicinal product)\Product containing only bictegravir and emtricitabine and tenofovir (medicinal product)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
• \Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing tenofovir (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing bictegravir and emtricitabine and tenofovir (medicinal product)\Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
• \Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing tenofovir (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
• \Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing pyrimidine (product)\Product containing emtricitabine (medicinal product)\Emtricitabine-containing product in oral dose form\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
• \Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing pyrimidine (product)\Product containing emtricitabine (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing bictegravir and emtricitabine and tenofovir (medicinal product)\Product containing only bictegravir and emtricitabine and tenofovir (medicinal product)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
• \Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing pyrimidine (product)\Product containing emtricitabine (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing bictegravir and emtricitabine and tenofovir (medicinal product)\Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
• \Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing pyrimidine (product)\Product containing emtricitabine (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
• \Product manufactured as oral dose form (product)\Emtricitabine-containing product in oral dose form\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet
• \Product manufactured as oral dose form (product)\Product containing tenofovir in oral dose form (medicinal product form)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Bictegravir and emtricitabine and tenofovir only product in oral dose form\Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Apr 2024. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
5310129017	Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5310130010	Product containing precisely bictegravir (as bictegravir sodium) 50 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start